PMID: 33157425 Hollinger A, von Felten S, Sutter R, Huber J, Tran F, Reinhold S, Abdelhamid S, Todorov A, Gebhard CE, Cajochen C, Steiner LA, Siegemund M (2020) Study protocol for a prospective randomised double-blind placebo-controlled clinical trial investigating a better outcome with melatonin compared to placebo administered to normalize sleep-wake cycle and treat hypoactive ICU delirium: the Basel BOMP-AID study
GLP-1 Tirz Tirzepatide GLP-1 Tirz 5mg (Lyophilized Peptide) For Research Use Only GLP-1 Tirz is a research-grade GLP-1 receptor agonist analog studied for its potential impact on appetite regulation, glucose control, insulin sensitivity, and metabolic health
J Kohll RX Compounding compounds formulations using semaglutide and tirzepatide, two GLP-1 receptor agonists that may be used when compounded alternatives are indicated
GLP-1 side effects are typically gastrointestinal (nausea, constipation, diarrhea) and often subside as the body adjusts to the medication